CEFTAZIDIME IN SEVERE INFECTIONS - A SWISS MULTICENTER STUDY

被引:28
作者
FRANCIOLI, P
CLEMENT, M
GEROULANOS, S
VONGRAEVENITZ, A
LUTHY, R
REGAMEY, C
STALDER, H
VOGT, M
WALDVOGEL, FA
机构
[1] HOP CANTONAL,SERV MED,FRIBOURG,SWITZERLAND
[2] UNIV ZURICH,KANTONSSPITAL,CHIRURG KLIN A,CH-8091 ZURICH,SWITZERLAND
[3] UNIV ZURICH,INST MED MIKROBIOL,CH-8006 ZURICH,SWITZERLAND
[4] UNIV ZURICH,KANTONSSPITAL,MED POLIKLIN,CH-8091 ZURICH,SWITZERLAND
[5] KANTONSSPITAL,MED KLIN,LIESTAL,SWITZERLAND
[6] HOP CANTONAL,DIV MALAD INFECT,GENEVE,SWITZERLAND
关键词
D O I
10.1093/jac/12.suppl_A.139
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:139 / 146
页数:8
相关论文
共 4 条
[1]  
BLASER J, DTSCH MED WOCHENSCHR
[2]   CEFTAZIDIME THERAPY OF SERIOUS BACTERIAL-INFECTIONS [J].
ERON, LJ ;
GOLDENBERG, RI ;
PARK, CH ;
PORETZ, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :236-241
[3]   ANTIBACTERIAL ACTIVITY AND BETA-LACTAMASE STABILITY OF CEFTAZIDIME, AN AMINOTHIAZOLYL CEPHALOSPORIN POTENTIALLY ACTIVE AGAINST PSEUDOMONAS-AERUGINOSA [J].
NEU, HC ;
LABTHAVIKUL, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :11-18